Ching-Tien Peng

Advisor
Division of Pediatric Hematology and Oncology, China Medical University Children's Hospital
Taichung City, Taichung, Taiwan (Republic of China)

Presentation(s):

• PB0492 - Fourth interim analysis of the HEM-POWR Study: A post hoc analysis of real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Taiwan

  Monday, June 24, 2024
  13:45 – 14:45 ICT